Hiv integrase inhibitors
AssigneeIstituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.
InventorsVincenzo Summa, Olaf Kinzel, Monica Donghi
Life of this patent
Estimating the term…
Loading patent…
AssigneeIstituto di Ricerche di Biologia Molecolare P. Angeletti S.p.A.
InventorsVincenzo Summa, Olaf Kinzel, Monica Donghi
Estimating the term…
Pyridopyrimidine carboxamide compounds of Formula I are inhibitors of HIV integrase and inhibitors of HIV replication: wherein R1, R2, R3, R4, R5 and R6 are defined herein. The compounds are useful for the prophylaxis or treatment of infection by HIV and the prophylaxis, treatment, or delay in the onset of AIDS. The compounds are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines.
A compound of Formula I, or a pharmaceutically acceptable salt thereof:
A compound, or a pharmaceutically acceptable salt thereof, selected from the group consisting of:
(canceled)
(canceled)
Dependencies are inferred from the claim text.